前收市價 | 354.51 |
開市 | 352.50 |
買盤 | 346.68 x 1000 |
賣出價 | 355.98 x 1000 |
今日波幅 | 351.42 - 355.15 |
52 週波幅 | 240.50 - 365.71 |
成交量 | |
平均成交量 | 1,533,041 |
市值 | 100.544B |
Beta 值 (5 年,每月) | 0.58 |
市盈率 (最近 12 個月) | 20.37 |
每股盈利 (最近 12 個月) | 17.40 |
業績公佈日 | 2024年5月02日 |
遠期股息及收益率 | 5.60 (1.58%) |
除息日 | 2024年6月04日 |
1 年預測目標價 | 383.14 |
Cigna Group, HCA Healthcare, Avantor and Tenet Healthcare are part of the Zacks top Analyst Blog.
Cigna plans to make close copies of AbbVie's blockbuster arthritis drug Humira available with no out-of-pocket payment to eligible patients in the U.S. using its specialty pharmacy beginning in June, the health insurer said on Thursday. Cigna said it will stock high- and low-concentration biosimilar versions of Humira from drugmakers including Boehringer Ingelheim, Teva and Alvotech at its Accredo pharmacy.
Walgreens is launching new services and consolidating specialty services to compete in the pharmacy benefits management (PBM) space.